The International Journal of Cancer Publishes Studies on the Anti-Cancer Activity of Generex Biotechnology's Immunotherapeutic Vaccine
31 juil. 2007 08h00 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 31, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) announced today publication in the peer-reviewed International Journal of Cancer (published online...